healthcare consortium
Regimen is here to consolidate healthcare segments and to become a major force in determining their future, by consolidating qualitative businesses, and to keep improving our services towards our customers, with Integrity and Transparency.
Preserve and enhance your legacy, by partnering with us.
Our unique approach, ensures you will continue taking care of your employees.
Our business outlook ensures the best reward for your business.
Our board consists of:
Stentiford is former Executive Vice President of GE; and former President and CEO of Alstom.
At GE he was responsible for a $1.5b global sales organization. This included sales marketing and globalization of the equity stake in Xian Electric China complimenting the legacy GE global portfolio in this group. Stentiford played key role in the ALSTOM Grid acquisition by GE, providing input and direction to the GE team before and during the successful completion of the acquisition. This was the single largest GE acquisition ever. This organization is today GE Grid Solutions LLC. While at Alstom, he had the responsibility for Alstom's annual $1b electrical transmission grid business in North America Region (Canada, Mexico, and USA); and before that the annual $1b transportation business in North America Region (Canada, and USA). He managed the integration of AREVA T&D Group NA into Alstom Group NA including restructuring divisions and departments and the creation of new regional companies. Stentiford while at NASDAQ-listed company Spescom Software, he raised venture capital to keep company afloat during the turnaround process. He also developed and managed investor relationships firms investment bankers and potential technology partners in support of the sale.Panorios, the President and Founder of Regimen Holdings, is a seasoned executive with extensive experience in commercial roles.
Since the recent loss of both his mother and father to dementia awakened a deep sense of purpose within him. It ignited a profound desire to raise awareness, support dementia patients, and ultimately contribute to the quest for prevention of this debilitating condition. He brings a strong network of top-level executives from the pharmaceutical, clinical laboratories, medical devices, and energy industries. Panorios specializes in fostering long-term growth opportunities that add value to customers and society. As an entrepreneur himself, he understands the challenges firsthand, having founded two companies in the leisure and mobile app industries. His leadership during military service showcases his ability to facilitate effective communication and collaboration between medical personnel and the broader team.Burr has 35 years of experience, including 25 years in public accounting specializing in tax and business advisory where he was responsible for coordinating professionals, engagements and serving clients.
His experience includes federal, state and international tax planning services for the following industries and sectors, including health care, service, technology, manufacturing, consumer products, and distribution companies. Burr also has significant SEC ASC 740, transaction advisory structuring, due diligence and planning. Tracy has significant experience with middle market companies that are focused on growth thru acquisitions. His background is unique for a Tax Partner as he has 10 years of experience as the CFO of two separate multi-billion-dollar international companies in the consumer products and distribution industries. Burr has experience working as a Tax Partner with RSM US LLP, EY LLP and Deloitte LLP. Tracy is a retired partner from RSM US LLP.Deem is an experienced senior professional who has operated in senior management, Board, and advisor capacities with companies ranging from start-up, to rapid growth, to large multi-national companies. Currently General Partner at SmartHealth Catalyzer and CEO of a startup. Formerly Entrepreneur in Residence at Khosla Ventures.
His intellectual bandwidth has benefited companies from a wide cross section of industries that include Life Sciences, Artificial Intelligence, Genomics, Data Science, Biotechnology, Energy, and Cancer Research. He is an active member of The National Association of Corporate Directors (NACD), and is available for select Board appointments. Certified by SAFe in Lean Portfolio Management, Agile, and Scrum. Deem recently finished his term as Department Chair of Bioengineering at Rice University. In this capacity, he oversaw a department with 20 tenure track faculty, 5 non- tenure track faculty and instructors, 20 support and research staff, 200 undergraduate and 125 graduate students, and an annual research and operating budget of approximately $27 million. The faculty represent a broad range of disciplines in bioengineering: basic physics of biology and cancer, synthetic and systems biology, multimodal imaging, machine learning, tissue engineering, and biomaterials. The department is consistently ranked in the top 10 programs in Biomedical Engineering.Ginter is the President & CEO of U.S. Mobile Health Exams, a mobile health testing and examination services provider, and the President of the North East Regional Urgent Care Association (NERUCA).
Previously he was the President of the Board of Directors of the Urgent Care Association (UCA). In addition to his UCA post, Ginter also currently held board positions with the Urgent Care Assurance Company, and the Urgent Care Political Action Committee (UCAPAC). He is a member of the American College of Health Care Executives (ACHE), National Association of Corporate Directors, and the Association of Corporate Growth. Before joining CareWell, he was the COO of Solantic Walk-In Urgent Care (now CareSpot | MedPost) in Florida, one of the nation's largest providers of urgent care, wellness and occupational health services. Additionally, he has held executive positions as the CEO of both Goverline and Blue Medical Supply, Inc. and was Regional VP for Rite Aid Drug stores. He is an expert in urgent care and the retail- and consumer-driven health evolution. Ginter brings deep expertise and proven experience drawn from his extensive, nationwide leadership in the retail/urgent care business. In addition, he was the President and CEO of Urgent Care Centers of New England/Emergence Healthcare Holdings, with 35 centers in the Northeast.Dr. Kapahi is Professor at Buck Institute for Research on Aging, and Adjunct Professor of Gerontology at the University of California.
He received his Ph. D. from the University of Manchester where he worked with Tom Kirkwood. He did his postdoctoral work with Seymour Benzer at Caltech and Michael Karin at the University of California at San Diego. He joined the Buck Institute as an Assistant Professor in 2004. Dr. Kapahi’s lab uses invertebrate models like C. elegans and D. melanogaster, and mice to understand how nutrients influence lifespan and age-related diseases. His laboratory has made significant contributions in the areas of nutrient responses, aging, and metabolism. He was the first to identify the role of the target of rapamycin (TOR) and implicate mRNA translation in mediating lifespan extension by dietary restriction. This work has led to a paradigm shift in the understanding of mechanistic underpinnings of dietary restriction (DR). TOR has emerged as one of the most promising targets for lifespan extension and age-related diseases. Inhibition of the TOR pathway has been shown to extend lifespan in yeast, worms, flies, and recently even mice. Another key contribution of the laboratory has been that modulation of mRNA translation, a critical output of the TOR pathway, plays a significant role in determining lifespan in worms and flies. His laboratory also identified a critical role for enhanced fat turnover and recently circadian clocks in mediating the lifespan extension upon DR. The Kapahi laboratory employs an interdisciplinary approach, combining biochemical, genetic, and genomic techniques, to understand how nutrients and AGEs modulate changes in lifespan and metabolism using D. melanogaster, C. elegans, and recently mammalian cell culture.We could have a confidential chat and see if there are any potential opportunities to be found between us on a 'nothing ventured, nothing gained' basis.